PAH and hepatocellular carcinoma: ,98,101 More recently, adenomas and an HCC were observed in an interim preclinical study to assess durability after AAV5-PAH in phenylalanine hydroxylase (PAH)-deficient mice, resulting in a clinical hold on the phase 1/2 study.168